vTv Therapeutics Inc
VTVT
Company Profile
Business description
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
Contact
3980 Premier Drive
Suite 310
High PointNC27265
USAT: +1 336 841-0300
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
23
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,631.50 | 42.70 | 0.50% |
CAC 40 | 7,826.79 | 1.34 | -0.02% |
DAX 40 | 24,226.49 | 198.84 | 0.83% |
Dow JONES (US) | 42,343.65 | 740.58 | 1.78% |
FTSE 100 | 8,778.05 | 60.08 | 0.69% |
HKSE | 23,381.99 | 99.66 | 0.43% |
NASDAQ | 19,199.16 | 461.96 | 2.47% |
Nikkei 225 | 37,724.11 | 192.58 | 0.51% |
NZX 50 Index | 12,582.33 | 35.11 | 0.28% |
S&P 500 | 5,921.54 | 118.72 | 2.05% |
S&P/ASX 200 | 8,407.60 | 46.60 | 0.56% |
SSE Composite Index | 3,340.69 | 6.15 | -0.18% |